Gts Securities LLC Crispr Therapeutics Ag Put Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$51.17 - $68.18 $445,179 - $593,166
8,700 Added 13.18%
74,700 $4.03 Million
Q1 2024

May 15, 2024
SELL
$60.67 - $89.12 $2.47 Million - $3.63 Million
-40,700 Reduced 38.14%
66,000 $4.5 Million
Q4 2023

Feb 14, 2024
BUY
$38.62 - $72.18 $1.65 Million - $3.07 Million
42,600 Added 66.46%
106,700 $6.68 Million
Q3 2023

Nov 15, 2023
BUY
$45.39 - $59.0 $2.91 Million - $3.78 Million
64,100 New
64,100 $2.91 Million

Others Institutions Holding CRSP

# of Institutions
523
Shares Held
58M
Call Options Held
1.73M
Put Options Held
1.84M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.69B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email